<DOC>
	<DOCNO>NCT00890214</DOCNO>
	<brief_summary>The researcher investigate influence prostacyclin analogue ( PGIA ) versus unfractionated heparin ( UFH ) ex vivo platelet function , continuous venovenous hemodiafiltration .</brief_summary>
	<brief_title>Prostacyclin 's Effect Platelet Responsiveness</brief_title>
	<detailed_description>Context purpose study : Prospective , randomized comparison PGIA versus UFH circuit anticoagulant . Platelet responsiveness assess peripheral blood light-transmittance aggregometry ( LTA ) induce collagen ADP , baseline , 4 24 hr treatment onset . Platelet function also assess blood sample collect circuit filter . The Setting University Hospital Intensive Care Unit . 23 ICU patient Acute Renal Failure need CVVHDF study standard CVVHDF therapy , random infusion extracorporeal circuit PGIA UFH .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<criteria>critically patient ill patient acute kidney failure ( AKI ) need renal replacement therapy therapy aspirin nonsteroidal antiinflammatory drug previous 7 day concomitant treatment extracorporeal organassist device drug affect coagulation platelet</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>Prostacyclin</keyword>
	<keyword>Heparin</keyword>
	<keyword>Renal Replacement Therapy</keyword>
	<keyword>Kidney failure acute</keyword>
	<keyword>Platelet aggregation</keyword>
</DOC>